Chirag Shah, MD

Publications

1. Shah CA, Brodsky M, Pomerantz R. The effect of progressive resistance strength training and nutritional supplementation on outcomes in the frail elderly. Jour Am Ger Soc. 48: 2000 Nov; S57.
2. Im SS, Gordon AN, Buttin BM, Leath CA 3rd, Gostout BS, Shah CA, Hatch KH, Wang J, Berman ML. Validation of referral guidelines for women with pelvic masses. Obstet Gynecol.105(1): 2005 Jan;35-41.
3. Shah CA, Johnson B, Everett E, Tamimi H, Greer B, Swisher E, Goff B. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol Oncol. 99(3): 2005 Dec; 564-570.
4. Shah CA, Pizer E, Veljovich DS, Drescher CW, Peters WA, Paley PJ. Clear cell adenocarcinoma of the vagina in a patient with vaginal endometriosis. Gynecol Oncol. 103(3): 2006 Dec;1130-1132.
5. Fox KV, Shah CA, Swisher EM, Garcia RL, Mandel LS, Swensen RE, Goff BA. An Evaluation of Cervical Cancer in Women Age Sixty and Over. Gynecol Oncol. 109(1): 2008 Apr:53-8.
6. Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, Swisher EM. Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. Gynecol Oncol. 109(2): 2008 May: 215-9.
7. Veljovich DS, Paley PJ, Drescher CW, Everett EN, Shah CA, Peters WA. Robotic Surgery in Gynecologic Oncology: Program initiation and outcomes after the first year with comparison to laparotomy for endometrial cancer staging. Am J Obstet Gynecol. 198(6): 2008 Jun: 679.e1-9.
8. Lowe K, Shah CA, Wallace E, Anderson G, Paley P, McIntosh M, Anderson R, Scholler N, Bergan L, Thorpe J, Urban N, Drescher C. Personal Characteristics Influence Serum CA125, Mesothelin, and HE4 Levels in Healthy Post-Menopausal Women at Increased Risk for Ovarian Cancer. Canc Epid Biom Prev. 2008 Sep;17(9):2480-7
9. Shah CA, Lowe K, Peters WA, Li CI, Goff BA. Factors Affecting Risk of Mortality in Women with Vaginal Cancer. Obstet Gynecol. 2009 May;113 (5)1038-45.
10. Shah CA, Lowe K, Wallace E, Anderson G, Paley P, McIntosh M, Anderson R, Scholler N, Bergan L, Thorpe J, Urban N, Drescher C. The Influence of Ovarian Cancer Risk-Status on the Diagnostic Performance of the Biomarkers Mesothelin, HE4 and CA125. Canc Epid Biom Prev. 2009 May;18(5):1365-72.
11. Gray HJ, Shah CA, Swensen RE, Tamimi HK, Goff BA. Alternative Intraperitoneal Chemotherapy Regimens for Optimally Debulked Ovarian Cancer. Gynecol Oncol. 2010 Mar; 116 (3)340-4.

Presentations

1. Shah C, Brodsky M, Pomerantz R. The Effect of Progressive Resistance Strength Training and Nutritional Supplementation on Outcomes in the Frail Elderly. Jour Am Ger Soc 48: 2000 Nov; S57. (Poster presented at American Federation for Aging Research and American Geriatrics Society Conference 5/01)
2. Im SS, Gordon AN, Buttin B, Leath CA, Gostout BS, Shah C, Hatch KH, Wang J, Berman ML. Assessment of SGO and ACOG referral guidelines for women with pelvic masses in identifying ovarian cancer patients. (Oral presentation at the Society of Gynecologic Oncology Meeting 2/04)
3. Shah C, Johnson B, Everett E, Tamimi H, Greer B, Swisher E, Swensen R, Gardella C, Goff B. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. (Poster presented at the Society of Gynecologic Oncology Annual Meeting 3/05)
4. Allison KH, Shah CA, Swisher EM. Type and degree of T cell immune response to ovarian carcinoma matters: Correlation of cytotoxic T cells and FoxP3+ immunosuppressive Tregs with survival. (Paper to be presented at the College of American Pathologists Annual Meeting 3/07)
5. Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, Swisher EM. Intratumoral T cells and tumor-associated macrophages: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. (Plenary paper presentation at the Society of Gynecologic Oncology Annual Meeting 3/07)
6. Fox KV, Shah CA, Swisher EM, Garcia RL, Mandel LS, Gray HJ, Swensen RE, and Goff BA,. An Evaluation of Cervical Cancer in Women over Sixty. (Paper presentation at the Western Association of Gynecologic Oncologists Annual Meeting 6/07)
7. Shah CA, Lowe K, Wallace E, Anderson G, Paley P, McIntosh M, Anderson R, Scholler N, Bergan L, Thorpe J, Urban N, Drescher C. The Influence of Ovarian Cancer Risk-Status on the Diagnostic Performance of the Biomarkers Mesothelin, HE4 and CA125 (Poster presentation at the Western Association of Gynecologic Oncologists Annual Meeting 6/08)
8. McLean KA, Shah CA, Thompson SA, Gray HJ, Greer BE, Swensen RE, Swisher EM, Tamimi HA, Goff BA. Ovarian Cancer in the Elderly: Outcomes with Neoadjuvant Chemotherapy or Primary Cytoreduction (Paper presentation at the Western Association of Gynecologic Oncologists Annual Meeting 6/08)
9. Shah CA, Lowe K, Peters WA, Li CI, Goff BA. Prognostic Factors for Survival in Women with Vaginal Cancer. (Poster presentation at the Society of Gynecologic Oncology Annual Meeting 2/09)
10. Shah CA, DelloRusso C, Gray HJ, Goff BA, Garcia RL, Swisher EM. Angiogenic Alterations Leading to Circulating Tumor DNA in Women with Ovarian Cancer. (Poster presentation at the Society of Gynecologic Oncology Annual Meeting 2/09)
11. Gray HJ, Shah CA, Swensen RE, Tamimi HK, Goff BA. Intraperitoneal catheter complications are not increased following cytoreductive surgery with bowel resection for ovarian cancer. (Poster presentation at the Society of Gynecologic Oncology Annual Meeting 2/09)
12. Gray HJ, Shah CA, Swensen RE, Tamimi HK, Goff BA. Life after 172: Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer. (Plenary paper presentation at the Society of Gynecologic Oncology Annual Meeting 2/09)
13. McLean KA, Shah CA, Thompson SA, Gray HJ, Greer BE, Swensen RE, Swisher EM, Tamimi HA, Goff BA. Pelvic Exenteration in the Age of Modern Chemoradiation. (Paper presentation at the Western Association of Gynecologic Oncologists Annual Meeting 6/09)
14. Shah CA, Gough S, Thorpe J, Hager S, Bergan L, Gaul M, Paley P, O’Briant K, Anderson G, McIntosh M, Urban N, Drescher C. Screening for Ovarian Cancer using the Parametric Empirical Bayes Algorithm: Results from a prospective screening cohort. (Plenary paper presentation the Society of Gynecologic Oncology Annual Meeting 3/10)